BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31306149)

  • 1. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
    Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
    Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers.
    Hata T; Dal Molin M; Hong SM; Tamura K; Suenaga M; Yu J; Sedogawa H; Weiss MJ; Wolfgang CL; Lennon AM; Hruban RH; Goggins MG
    Clin Cancer Res; 2017 Jul; 23(14):3935-3944. PubMed ID: 28148542
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous and sequential combination of genetic and epigenetic biomarkers for the presence of high-grade dysplasia in patients with pancreatic cyst: Discovery in cyst fluid and test in pancreatic juice.
    Hata T; Mizuma M; Kusakabe T; Amano H; Furukawa T; Iwao T; Unno M
    Pancreatology; 2023 Mar; 23(2):218-226. PubMed ID: 36707261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
    Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
    Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts.
    Heidarian A; Das KK; Mino-Kenudson M; Fernandez-Del Castillo C; Pitman MB
    J Am Soc Cytopathol; 2021; 10(3):249-254. PubMed ID: 33541830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls.
    Majumder S; Raimondo M; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Devens ME; Mahoney DW; Smyrk TC; Pannala R; Chari ST; Vege SS; Topazian MD; Petersen BT; Levy MJ; Rajan E; Gleeson FC; Abu Dayyeh B; Nguyen CC; Faigel DO; Woodward TA; Wallace MB; Petersen G; Allawi HT; Lidgard GP; Kisiel JB; Ahlquist DA
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):676-683.e3. PubMed ID: 31323382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower cyst fluid carcinoembryonic antigen cutoff is helpful in the differential diagnosis of mucinous versus non-mucinous pancreatic cysts.
    Sharma RK; Bush N; Rana SS; Srinivasan R; Nada R; Gupta R; Rana S; Singh T
    Indian J Gastroenterol; 2022 Aug; 41(4):397-404. PubMed ID: 36057043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Simple Mucinous Cyst" of the Pancreas: A Clinicopathologic Analysis of 39 Examples of a Diagnostically Challenging Entity Distinct From Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms.
    Krasinskas AM; Oakley GJ; Bagci P; Jang KT; Kuan SF; Reid MD; Erbarut I; Adsay V
    Am J Surg Pathol; 2017 Jan; 41(1):121-127. PubMed ID: 27740966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Molecular Analysis into the Pathologic Evaluation of Pancreatic Cysts.
    Bell PD; Singhi AD
    Surg Pathol Clin; 2022 Sep; 15(3):455-468. PubMed ID: 36049828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
    Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
    Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple mucinous cyst: another potential cancer precursor in the pancreas? Case report with molecular characterization and systematic review of the literature.
    Milanetto AC; Tonello AS; Valotto G; Munari G; Luchini C; Fassan M; Pasquali C
    Virchows Arch; 2021 Jul; 479(1):179-189. PubMed ID: 33511431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts.
    Basar O; Yuksel O; Yang DJ; Samarasena J; Forcione D; DiMaio CJ; Wagh MS; Chang K; Casey B; Fernandez-Del Castillo C; Pitman MB; Brugge WR
    Gastrointest Endosc; 2018 Jul; 88(1):79-86. PubMed ID: 29510146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
    Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
    Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts.
    Al-Haddad M; DeWitt J; Sherman S; Schmidt CM; LeBlanc JK; McHenry L; Coté G; El Chafic AH; Luz L; Stuart JS; Johnson CS; Klochan C; Imperiale TF
    Gastrointest Endosc; 2014 Jan; 79(1):79-87. PubMed ID: 23845445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.